Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:09 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
NCT03685773 · Albert Einstein College of Medicine · PHASE2 · withdrawn · last registry update 2023-06-05 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Permanently terminated due to COVID-19 given the poor vaccine penetrance in liver transplant recipients. This is not a suspension of IRB approval.” | – | Registry record, Albert Einstein College of Medicine |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against KCNJ11 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-05-01Results posted on the registry: Massachusetts General Hospital, Glipizide + Metformin (NCT01762046)
- 2023-11-30Results posted on the registry: The University of Texas Health Science Center at San Antonio, Dapagliflozin + Metformin (NCT02911792)
- 2023-10-06Results posted on the registry: Pfizer, Ritlecitinib + Tolbutamide (NCT05097716)
- 2023-09-21Results posted on the registry: Soleno Therapeutics, Inc., DCCR + Placebo for DCCR (NCT03440814)
- 2023-09-13Also stopped (withdrawn): University of Minnesota, Post-Laser Minoxidil 2% + At-Home Minoxidil 5% (NCT03852992)
- 2023-08-21Phase 3 first posted: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy, Dapagliflozin 10mg Tab + Placebo (NCT05998837)
- 2023-08-14Phase 3 first posted: Universitas Indonesia, Minoxidil 5% Topical Solution (NCT05989165)
- 2023-08-14Phase 3 first posted: Universitas Indonesia, Finasteride + Minoxidil (NCT05990400)
- 2023-08-01Results posted on the registry: Galderma R&D, Treatment: Minoxidil 2% / Botanical Hair Solution for Women (NCT02460497)
- 2023-08-01Results posted on the registry: Galderma R&D, Treatment: Minoxidil 5% / Botanical Hair Solution for Men (NCT02460289)
- 2023-06-05Phase 3 first posted: Industrial Farmacéutica Cantabria, S.A., Minoxidil Tablets + Minoxidil Topical (NCT05888922)
- 2023-01-27Phase 3 first posted: Soleno Therapeutics, Inc., DCCR (NCT05701774)
- 2022-09-19Also stopped (withdrawn): Johns Hopkins University, IV Diazoxide (NCT04830982)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision